Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
eyeThera
AddedFeb 17, 2024
UpdatedJun 18, 2026
eyeThera

eyeThera

Angel

EyeThera, a medical device company, designs thermaShield for enhanced RF energy control and cosmetic benefits.

HQ
Kennebunk, ME, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

EyeThera, founded with a mission to enhance ocular health and cosmetic outcomes, focuses on developing innovative medical devices. Their flagship product, thermaShield, is designed to assist physicians in using RF energy around the eyelid, providing patients with cosmetic benefits like reduced fine lines and wrinkles while offering physicians improved control over corneal shields. EyeThera targets the ophthalmology and cosmetic surgery markets, addressing conditions such as Dry Eye Disease and promoting overall eye wellness.

Notable figures affiliated with EyeThera include leading ophthalmologists and medical device experts who contribute to its research and development. The company has garnered attention from investors interested in cutting-edge medical technologies. Key achievements include the successful launch and adoption of thermaShield by practitioners, positively impacting patient outcomes by combining therapeutic and aesthetic benefits. EyeThera continues to make significant strides in the medical device industry, enhancing both patient care and physician capabilities.

eyeThera - Similar Companies

LumiThera logo

LumiThera

lumithera.com

Eyedea Medical logo

Eyedea Medical

eyedeamedical.com

Eyes 4 Lives logo

Eyes 4 Lives

EyeCyte logo

EyeCyte

eyecyte.com

Hyperion DeFi logo

Hyperion DeFi

eyenovia.com

EyeNetra logo

EyeNetra

eyenetra.com

EyeScience Labs logo

EyeScience Labs

Oculogica logo

Oculogica

oculogica.com

EyeIC logo

EyeIC

ExThera Medical logo

ExThera Medical

extheramedical.com

Eyedaptic logo

Eyedaptic

eyedaptic.com

Retina Technologies logo

Retina Technologies

Eyebot logo

Eyebot

eyebot.tech

OcuMedic logo

OcuMedic

PhotoThera logo

PhotoThera

eyeThera - Quick Facts

Who are eyeThera's competitors?

Companies similar to eyeThera include LumiThera, Eyedea Medical, Eyes 4 Lives and EyeCyte.

When was eyeThera founded?

eyeThera was founded in 2014.

Where is eyeThera's headquarters located?

eyeThera's headquarters is located in Kennebunk, ME, US.

When was eyeThera's last funding round?

eyeThera's most recent funding round was for $45.3k (USD) in January 2020.

How much has eyeThera raised to-date?

As of Jan 1, 2020, eyeThera has raised a total of $45.3k (USD).

How many employees does eyeThera have?

eyeThera has 5 employees as of Feb 4, 2024.

eyeThera - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • RFID
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthtech
  • Physicians
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified